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Ischemia-reperfusion injury, a form of sterile inflammation, is the leading risk factor for both short-term mortality following
pulmonary transplantation and chronic lung allograft dysfunction. While it is well recognized that neutrophils are critical
mediators of acute lung injury, processes that guide their entry into pulmonary tissue are not well understood. Here, we found
that CCR2+ classical monocytes are necessary and sufficient for mediating extravasation of neutrophils into pulmonary tissue
during ischemia-reperfusion injury following hilar clamping or lung transplantation. The classical monocytes were mobilized
from the host spleen, and splenectomy attenuated the recruitment of classical monocytes as well as the entry of neutrophils
into injured lung tissue, which was associated with improved graft function. Neutrophil extravasation was mediated by
MyD88-dependent IL-1β production by graft-infiltrating classical monocytes, which downregulated the expression of the tight
junction–associated protein ZO-2 in pulmonary vascular endothelial cells. Thus, we have uncovered a crucial role for classical
monocytes, mobilized from the spleen, in mediating neutrophil extravasation, with potential implications for targeting of
recipient classical monocytes to ameliorate pulmonary ischemia-reperfusion injury in the clinic.

Introduction

Ischemia-reperfusion injury (IRI) following solid organ transplantation is mediated by host neutrophils that, upon extravasation,
initiate NETosis and induce allograft damage (1, 2). Following lung
transplantation, IRI leads to primary graft dysfunction in over 50%
of lung recipients, which is the predominant risk factor for early mortality as well as chronic rejection and thus late mortality (3–6). While
depletion of neutrophils can ameliorate IRI, it can also compromise
the pathogen-directed response of the host (7–11). Elucidating the
mechanisms of neutrophil trafficking into the allograft is, therefore,
crucial to developing clinically applicable therapies against IRI.
Blood monocytes can be classified into nonclassical and classical subtypes based on cell surface markers (12, 13). Classical monocytes are characterized by a high expression of the cell-surface molecule Ly6C and the presence of the chemokine receptor CCR2. They
are the predominant monocytes found in the circulation, where they
survey organ spaces and readily respond to inflammatory cues. Classical monocytes are generally regarded as “proinflammatory,” as
they are readily recruited to sites of infectious and sterile inflamma-
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tion, where they elaborate proinflammatory cytokines and differentiate into macrophages and dendritic cells (13). Nonclassical monocytes, in contrast, lack expression of CCR2, but express low levels of
Ly6C and high levels of the fractalkine receptor CX3CR1. These cells
patrol the microvasculature in a CX3CR1-dependent manner, and
although less is known about the development and function of nonclassical monocytes, recent studies have implicated this monocyte
subtype in various inflammatory processes (14–21). The precise role
of monocytes in mediating neutrophil migration into injured tissues
remains unclear. We recently found that donor-derived nonclassical
monocytes are necessary for early neutrophil recruitment through
the production of the neutrophil chemoattractant MIP-2 and that
depletion of these cells ameliorates lung IRI (21). Interestingly, using
intravital 2-photon imaging, we have previously observed that circulating monocytes facilitate neutrophil trafficking into freshly reperfused lungs. Furthermore, we found that pulmonary graft function
is significantly improved when lung-transplant recipients lack CCR2
expression, which impairs recruitment of classical monocytes to
lung grafts (9, 22). Since both recruitment to the tissue and extravasation of neutrophils into the extravascular space are necessary for
the initiation and propagation of lung IRI (23), it can be postulated
that classical monocytes are perhaps essential for neutrophil extravasation. Therefore, we hypothesized that nonclassical and classical
monocytes may have complementary roles in the development of
IRI, in which nonclassical monocytes provide the initial signals for
leukocyte recruitment, while host-derived classical monocytes are
essential for the extravasation of neutrophils into the injured lungs.
jci.org   Volume 128   Number 7   July 2018
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Figure 1. Classical monocytes recruited to the lung after IRI mediate neutrophil extravasation. WT mice underwent IRI using hilar clamping, and the
myeloid cell populations were analyzed by flow cytometry. (A) Representative flow cytometry plots (left) and quantification (right) of extravasated neutrophils and recruited classical monocytes (CM) in resting state or that of hilar clamp–mediated IRI are demonstrated. Neutrophils and classical monocytes
were gated on live CD45+Ly6G+CD11b+SSChi and live CD45+Ly6G–NK1.1–SiglecF–CD11b+CD64–Ly6Chi cells, respectively. (B) Correlation between recruitment of
classical monocytes following reperfusion of human lung allografts and increase in neutrophils in the BALF. The ratio of classical monocytes normalized
by alveolar macrophages was correlated with an increase in bronchoalveolar neutrophils before and 15 minutes following reperfusion. Pearson’s correlation
coefficient (r) was significant. (C) The percentage of extravasated neutrophils was determined after hilar clamp–mediated IRI in mice that were systemically depleted of monocytes 24 hours prior to IRI using Clo-lip (left), DT (CD11b-DTR mouse; middle), or anti-CCR2 antibody treatment (right). Data are
expressed as median with interquartile range. n = 5–13 per group. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, Mann-Whitney U test (A and C).

In both human lung allografts and murine models, we found
that IRI was associated with the recruitment of classical monocytes as well as neutrophils into the injured lungs. The classical
monocytes were mobilized from the host spleen and were necessary for neutrophil extravasation, since pharmacological depletion
of CCR2+ classical monocytes as well as splenectomy abrogated
neutrophil extravasation, while heterotopic spleen transplantation following initial splenectomy rescued the injury. To achieve
clinical relevance, we validated these findings in an orthotopic
vascularized murine lung-transplant model (24). We found that
host splenectomy ameliorated IRI, while reconstitution with
spleen-
derived classical monocytes restored IRI. Neutrophil
extravasation was mediated by MyD88-dependent IL-1β production by classical monocytes, which resulted in downregulation of
ZO-2, a cytoplasmic protein that interacts with transmembrane
tight junctional proteins, in pulmonary vascular endothelial cells.
2834

jci.org   Volume 128   Number 7   July 2018

IL-1β–mediated downregulation of ZO-2 was sufficient to increase
endothelial permeability. Thus, our work uncovers what we
believe to be a previously unrecognized mechanism by which classical monocytes mobilized from the spleen promote extravasation
of recruited neutrophils into the lung following IRI.

Results

Classical monocytes are necessary for neutrophil extravasation following lung IRI. We and others have demonstrated that host neutrophils are critical mediators of lung IRI (2, 7–11, 25). Using our
previously described technique of multicolor flow cytometry
(26–29), we determined the changes in myeloid cell populations in
the lung following IRI that was mediated by transient clamping of
the pulmonary hilum. We observed that classical monocytes were
recruited and host neutrophils extravasated into the lung while the
number of nonclassical monocytes remained unchanged after IRI

The Journal of Clinical Investigation  
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Figure 2. Classical monocytes mediating neutrophil extravasation in lungs subjected to IRI through hilar clamping are mobilized from the spleen.
Numbers of classical monocytes in the (A) lung, (B) spleen, and (C) bone marrow before and 2 hours after hilar clamp–mediated lung IRI. Numbers of
classical monocytes in the lung and spleen are shown after treatment with isotype control or anti-CCR2 antibody. (D) Numbers of classical monocytes in
bone marrow of resting mice after treatment with isotype control or anti-CCR2 antibody. Data are expressed as median with interquartile range. n = 5 per
group. *P < 0.05, Mann-Whitney U test. (E) Recruitment of classical monocytes to injured lung and (F) percentage of extravasated neutrophils in injured
lung after hilar clamp–mediated IRI in the presence or absence of a spleen. Congenic spleen transplants were performed into hosts that had undergone
native splenectomies. Splenectomy of the transplanted spleen (resplenectomy) rendered these mice asplenic. txp, transplant. For E, 1 statistical outlier
in the spleen transplant and 1 statistical outlier in resplenectomy group were excluded from the analysis. For F, 1 statistical outlier was excluded in the
splenectomy group. Data are expressed as mean ± SEM. n = 6–8 per group. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, 1-way ANOVA with post
hoc Holm-Šídák test (A–C, E, F).

(Figure 1A, Supplemental Figure 1, and Supplemental Figure 2A;
supplemental material available online with this article; https://
doi.org/10.1172/JCI98436DS1). We also observed an increase
in neutrophils and classical, but not nonclassical, monocytes in
human lung allografts following reperfusion (Supplemental Figure 3). The increase in classical monocytes in human lung grafts
correlated with an accumulation of neutrophils in the bronchoalveolar lavage fluid (BALF) (Figure 1B).
In order to determine whether classical monocytes were
responsible for neutrophil extravasation, we first depleted all circulating monocytes by pretreating the host with clodronate liposomes (Clo-lip), a technique we have previously demonstrated
as causing monocytopenia for at least 72 hours (Supplemental
Figure 2B and Supplemental Figure 4) (16). This led to a significant decrease in neutrophil extravasation following lung IRI (Figure 1C). Similarly, we found a significant reduction in neutrophil
extravasation in CD11b-DTR mice after monocytes were depleted
using diphtheria toxin (DT) (Figure 1C, Supplemental Figure 2C,
Supplemental Figure 4, A and B). Since Clo-lip treatment results

in depletion of both classical and nonclassical monocytes in WT
mice and there exists a possibility that administration of DT could
also deplete neutrophils in CD11b-DTR mice, we next treated WT
hosts with anti-CCR2 antibodies to selectively deplete classical
monocytes (Supplemental Figure 2D and Supplemental Figure 4,
A and B), as previously described (21). Anti-CCR2 antibody treatment significantly reduced neutrophil extravasation, indicating
that classical monocytes may mediate this process (Figure 1C).
The spleen is necessary for the recruitment of classical monocytes
and neutrophil extravasation into the injured lung. Both bone marrow and spleen are sites where monocytes can be recruited from
in models of lung inflammation (30). We first set out to analyze
classical monocytes in different compartments following lung IRI.
While the injured lungs showed an increase in classical monocytes
(Figure 2A), levels of classical monocytes were decreased in the
host spleen (Figure 2B), but remained constant in the bone marrow before and after injury (Figure 2C). Administration of antiCCR2 antibodies resulted in a significant reduction of classical
monocytes in both spleen and bone marrow at baseline (Figure 2,
jci.org   Volume 128   Number 7   July 2018
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Figure 3. Classical monocytes are mobilized from the recipient’s spleen to lung grafts after transplantation. (A) Representative contour plots and
histograms depict recipient (CD45.2+) CD11b+Ly6chiCCR2+ monocytes in pulmonary grafts and peripheral blood 2 hours after transplantation of B6 CD45.1+
lungs into control or splenectomized congenic B6 CD45.2+ mice. (B) Graphic presentation of monocytes as percentages of recipient CD45.2+ hematopoietic
cells and absolute numbers in lung grafts and peripheral blood. Data are expressed as median with interquartile range. n = 4 per group. *P < 0.05, unpaired
t test. (C) A CCR2-specific PET radiotracer (64Cu-DOTA-ECL1i) was injected into control (left) or splenectomized (right) B6 recipients of syngeneic lung grafts
2 hours after transplantation and imaged by 0- to 60-minute dynamic PET/CT scanning after intravenous injection. L, liver; K, kidney; B, bladder. Circle
shows lung graft. (D) Graphic presentation of 64Cu-DOTA-ECL1i uptake in native right lungs and pulmonary grafts 2 hours after transplantation into control
or splenectomized syngeneic B6 recipients. Data are expressed as mean ± SEM. n = 4 per group. *P < 0.05; **P < 0.01; ****P < 0.0001, 1-way ANOVA with
post hoc Holm-Šídák test. (E) Depletion of nonclassical monocytes in B6 donor lungs through Clo-lip or genetic deletion of NR4A1 led to a reduction in the
serum MCP-1 levels of the BALB/c recipient 2 hours after reperfusion compared with control PBS-liposome treatment mice. (F) Recruitment of BALB/c
recipient classical monocytes into the B6 allograft was significantly reduced 2 hours after reperfusion when donor lungs were treated with Clo-lip to
deplete donor nonclassical monocytes or when NR4A1–/– donor lungs were used. Reconstitution of B6 NR4A1–/– lungs with WT B6 nonclassical monocytes
prior to transplantation restored the levels of classical monocytes recruited to the donor allograft following reperfusion. Data are expressed as mean ±
SEM. n = 5–8 per group. ****P < 0.001, 1-way ANOVA with post hoc Holm-Šídák test (E and F).

B and D). After reperfusion, treatment with anti-CCR2 antibody
resulted in a significant reduction of classical monocytes in lungs
and spleen (Figure 2, A and B). To determine whether classical
monocytes can be recruited directly from the bone marrow, we
performed a splenectomy, which resulted in a significant reduction in the recruitment of classical monocytes to the injured lungs
along with a decrease in neutrophil extravasation, suggesting that
the spleen serves as a reservoir for the inflammatory classical
2836
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monocytes (Figure 2, E and F, and Supplemental Figure 2E). Splenectomy did not alter the number of nonclassical monocytes in
injured lungs (Supplemental Figure 2E). In order to further explore
this hypothesis, we performed heterotopic congenic spleen transplants (CD45.1 donor into CD45.2 recipient) after native splenectomy, as previously described (31). We found that the donor spleen
was repopulated by host-derived myeloid cells and, at 1 week,
greater than 95% of classical monocytes were of recipient origin

The Journal of Clinical Investigation  
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Figure 4. Spleen-derived classical monocytes promote neutrophil extravasation into lung grafts after transplantation. (A) Arterial blood oxygenation
was assessed, and absolute numbers of neutrophils were determined in (B) lung grafts 24 hours after transplantation of B6 CD45.1+ lungs into control or
splenectomized congenic B6 CD45.2+ recipients. (C) Contour plots depicting gating strategy to identify intravascular vs. extravascular recipient neutrophils
(CD45.2+CD11b+Gr-1+) and quantification of the percentage of graft-infiltrating neutrophils 24 hours after transplantation of B6 CD45.1+ lungs into control or
splenectomized congenic B6 CD45.2+ hosts. Debris, dead cells, and doublets have been excluded from analysis based on forward scatter/side scatter (FSC/
SSC) and FSC–pulse area [FSC-A]/FSC–pulse width [FSC-W] characteristics. (D) Absolute numbers of neutrophils were determined in the BALF 24 hours
after transplantation of B6 CD45.1+ lungs into control or splenectomized congenic B6 CD45.2+ recipients. Data for A–D are expressed as median with interquartile range. n = 4 per group for arterial blood gas measurement; n = 7 per group for enumeration of neutrophils in lung grafts and BALF. *P < 0.05; **P <
0.01, Mann-Whitney U test. (E) Expression levels of Il1b, Tnfa, Cxcl1, Cxcl2, and Cxcl5 in B6 CD45.1+ lung grafts 24 hours after transplantation into control or
splenectomized congenic B6 CD45.2+ hosts, assessed by quantitative real-time PCR. Results were normalized to Rn18s. Data are expressed as median with
interquartile range. n = 5 per group. *P < 0.05; **P < 0.01, Mann-Whitney U test.

(Supplemental Figure 5). Mice that underwent a native splenectomy and received heterotopic spleen transplants demonstrated
preserved recipient-derived classical monocyte infiltration into
the lung as well as neutrophil extravasation following pulmonary
IRI. Moreover, removal of the transplanted spleen prior to lung
IRI abrogated classical monocyte recruitment and neutrophil
extravasation, which was similar to our observations in WT mice
after splenectomy (Figure 2, E and F). This further confirmed the
importance of the spleen as a source of inflammatory classical
monocytes that are recruited to injured lungs. Notably, splenectomy did not affect neutrophil extravasation in other models of lung
injury, including administration of intratracheal LPS or acid aspiration (Supplemental Figure 6).
Next, to achieve clinical relevance, we used a murine vascularized lung-transplant model to investigate the role of the spleen
as a reservoir for inflammatory classical monocytes. Unlike the
hilar clamp model, in which the lungs are subjected to warm ischemia, the lung-transplant model mimics the clinical situation in
which lungs undergo a period of cold ischemia prior to reperfusion
(24). We splenectomized recipient C57BL/6 (B6) CD45.2 mice
prior to transplantation of congenic B6 CD45.1 lungs. The abundance of classical monocytes was significantly decreased in the

peripheral blood and lung grafts when compared between splenectomized and nonsplenectomized recipients after reperfusion
(Figure 3, A and B). Using PET/CT with our recently described
CCR2-specific imaging probe, we observed that, after removal of
the recipient spleen, the signal in the lung graft was significantly diminished at 2 hours after transplantation, which was similar
to our previous observations in CCR2-deficient lung-transplant
recipients (Figure 3, C and D) (22). Moreover, there was an overall
decrease in PET signal in the periphery of splenectomized hosts.
Thus, similarly to what we found in our observations in the hilar
clamp model, the spleen is an important reservoir for inflammatory classical monocytes that infiltrate transplanted lungs immediately after reperfusion. Given that we have previously shown
that donor nonclassical monocytes mediate the recruitment of
recipient neutrophils into pulmonary grafts, we next set out to
determine whether nonclassical monocytes played a role in the
recruitment of classical monocytes into the transplanted lung
(21). At baseline, classical monocytes were more abundant in
both bone marrow and spleen compared with nonclassical monocytes (Supplemental Figure 7). However, while more classical
monocytes were present in the bone marrow compared with the
spleen, we observed more nonclassical monocytes in the spleen
jci.org   Volume 128   Number 7   July 2018
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Figure 5. IL-1β production by graft-infiltrating monocytes is essential for neutrophil extravasation after lung transplantation. (A) Recipient monocytes (CD45.2+CD11b+Ly6Chi) were isolated from the bone marrow or lung grafts in resting mice or 2 hours after transplantation of B6 CD45.1+ lungs into
B6 CD45.2+ recipients, and their expression levels of Il1b, Tnfa, Cxcl1, Cxcl2, and Cxcl5 were analyzed by quantitative PCR. n = 4 each compartment with 1
statistical outlier for Cxcl1 and 1 statistical outlier for Cxcl5 in the lung excluded from analysis. *P < 0.05, Mann-Whitney U test. (B) Expression levels of
IL1B in human donor grafts at conclusion of cold ischemia and 2 hours after reperfusion, assessed by quantitative PCR. n = 5. **P < 0.01, paired t test. (C)
Arterial blood oxygenation was assessed and absolute numbers of recipient (D) monocytes and (E) neutrophils were determined in lung grafts 24 hours
after transplantation of B6 CD45.1+ lungs into splenectomized congenic B6 CD45.2+ recipients that received either B6 WT or B6 IL-1β–deficient monocytes.
Data are expressed as median with interquartile range. n = 6 per group. **P < 0.01, Mann-Whitney U test. (F) Representative contour plots of extravascular
vs. intravascular neutrophils and quantification of the percentage of graft-infiltrating neutrophils in lung grafts and (G) number of neutrophils in BALF 24
hours after transplantation of B6 CD45.1+ lungs into splenectomized B6 CD45.2+ recipients that received B6 WT or B6 IL-1β–deficient monocytes. Data are
expressed as median with interquartile range. n = 6 per group. *P < 0.05; **P < 0.01, Mann-Whitney U test. (H) Representative intravital 2-photon microscopy of B6 WT or B6 IL-1R–KO lung grafts 2 hours after transplantation into syngeneic B6 LysM-GFP mice and quantification of neutrophil extravasation.
Qdot 655 labeled the vessels red. Recipient neutrophils are green. Scale bar: 50 μm. Data are expressed as median with interquartile range. n = 4 per group.
*P < 0.05, Mann-Whitney U test.
2838
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compared with the bone marrow (Supplemental Figure 7). We
observed that serum levels of the CCR2 ligand MCP-1 were significantly reduced after lung transplantation when grafts were
devoid of nonclassical monocytes, which was achieved by pretreating lung donors with Clo-lip injection or by using donors that
were deficient in NR4A1, a transcription factor that is necessary
for the development of nonclassical monocytes (Figure 3E) (17).
Recruitment of classical monocytes was significantly reduced
after transplantation of donor lungs that lack nonclassical monocytes (Figure 3F). Importantly, reconstitution of NR4A1-deficient
grafts with WT nonclassical monocytes restored the recruitment
of classical monocytes to the transplanted lung. Thus, in addition
to their previously reported role in mediating neutrophil recruitment, donor nonclassical monocytes promote the recruitment of
classical monocytes from the recipient’s spleen.
Having shown that spleen-derived classical monocytes infiltrate lung grafts shortly after reperfusion, we next set out to determine whether IRI following lung transplantation is affected by the
removal of the recipient’s spleen. Compared with what occurred
in control recipients, graft function was significantly better in
splenectomized hosts (Figure 4A). Since neutrophils play a crucial
role in lung IRI, we next compared neutrophil graft infiltration
in nonsplenectomized and splenectomized lung recipients. Host
splenectomy prior to lung transplantation resulted in an overall
reduction of recipient neutrophils in the graft tissue (Figure 4B).
Splenectomy resulted in a significant decrease in the percentage
of neutrophils that exited the vascular compartment (Figure 4C)
and a lower abundance of neutrophils in the airways (Figure 4D),
indicating a lower degree of tissue entry and thus supporting the
notion that classical monocytes are necessary for the extravasation of host neutrophils following lung IRI. Graft function and
neutrophil extravasation in recipients that underwent a sham laparotomy prior to lung transplantation were comparable to that in
nonsplenectomized hosts (Supplemental Figure 8, A and B). Furthermore, we observed significantly lower levels of the proinflammatory cytokines Il1b and Tnfa (Figure 4E) as well as the neutrophil chemokines Cxcl1 and Cxcl2, but not Cxcl5 transcripts in lung
grafts after transplantation into splenectomized hosts (Figure 4E).
Monocyte-derived IL-1β plays a critical role in neutrophil
extravasation. In order to elucidate how monocytes regulate
neutrophil graft infiltration and their extravasation, we sorted recipient-derived graft-infiltrating classical monocytes and
analyzed their gene expression by quantitative reverse-transcription PCR (RT-PCR). Compared with classical monocytes
that were concurrently isolated from the bone marrow of these
lung-transplant recipients, Il1b expression levels were several
thousandfold higher in graft-infiltrating classical monocytes
shortly after reperfusion (Figure 5A). Expression levels of Tnfa
and Cxcl2 were also increased in graft-infiltrating monocytes,
although they were less pronounced than Il1b (Figure 5A). At
baseline, we also observed higher expression of Il1b, Tnfa,
and Cxcl2 in lung compared with bone marrow monocytes,
although the differences were less pronounced than after IRI
(Supplemental Figure 9). Fractalkine/Cx3cl1 expression could
not be detected in monocytes in either compartment (data not
shown). Expression levels of IL1B, but not TNFA, were found to
be significantly elevated in human lung grafts after reperfusion
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(Figure 5B and Supplemental Figure 10). Based on the markedly elevated levels of IL-1β in graft-infiltrating classical monocytes, we next evaluated whether expression of this cytokine in
monocytes regulated neutrophil extravasation into lung grafts
during IRI. To this end, we injected splenic classical monocytes isolated from either WT or IL-1β–deficient B6 CD45.2
mice into splenectomized B6 CD45.2 recipients 1 hour prior to
transplantation of congenic B6 CD45.1 lungs. Graft function
was significantly better after injection of IL-1β–deficient compared with WT classical monocytes (Figure 5C). In fact, graft
function after adoptive transfer of WT classical monocytes into
splenectomized recipients was comparable to that observed
after lung transplantation into nonsplenectomized hosts,
while graft function after adoptive transfer of IL-1β–deficient
classical monocytes into splenectomized recipients was not
significantly different from that in splenectomized recipients
that did not receive monocyte injections (Figure 4A). While
the absolute numbers of classical monocytes and neutrophils
in lung grafts did not differ between the 2 experimental adoptive transfer groups (Figure 5, D and E), a higher percentage
of graft-infiltrating neutrophils had left the vascular compartment (Figure 5F) and a greater number of neutrophils had
entered the airways (Figure 5G) after adoptive transfer of WT
compared with IL-1β–deficient classical monocytes. To confirm
that IL-1β signaling regulates neutrophil trafficking in freshly
reperfused lung grafts, we transplanted lungs that lack expression of the IL-1 receptor (IL-1R) into syngeneic LysM-GFP
neutrophil reporter mice and imaged the grafts by intravital
2-photon microscopy 2 hours after reperfusion. Corroborating
our flow cytometry data, we observed that, compared with WT
grafts, neutrophils failed to extravasate efficiently in IL-1R–
deficient lungs (Figure 5H) (Supplemental Videos 1 and 2). We
then compared IL-1β expression in bone marrow and splenic
classical monocytes in resting mice and after lung transplantation. Under both conditions, IL-1β expression was significantly
increased in splenic monocytes, with a more pronounced difference after lung transplantation (Supplemental Figure 11A).
Of note, as opposed to reconstitution with splenic monocytes,
injection of bone marrow monocytes into splenectomized hosts
did not restore neutrophil extravasation into pulmonary grafts
or result in an impairment in oxygen exchange (Supplemental
Figure 11, B and C).
MyD88 signaling in graft-infiltrating classical monocytes is necessary for IL-1β production and neutrophil extravasation. We and others
have shown that endogenous substances, which are released at the
time of organ implantation, can activate innate immune receptors
and trigger the release of proinflammatory cytokines, such as IL-1β
(32). Many such endogenous triggers of inflammation, referred to
as damage-associated molecular patterns, signal via MyD88, an
adaptor protein downstream of all TLRs except TLR3 and downstream of IL-1 and IL-18 receptors. We next examined requirements
for IL-1β production in monocytes after stimulation with lysates
generated from B6 lungs. Expression levels of IL-1β were significantly decreased when monocytes lacked MyD88 (Figure 6A). To
assess the role of MyD88 signaling in graft-infiltrating monocytes in
vivo, we transferred splenic classical monocytes from either WT or
MyD88-deficient B6 CD45.2 mice into splenectomized B6 CD45.2
jci.org   Volume 128   Number 7   July 2018
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Figure 6. MyD88 expression by graft-infiltrating monocytes is essential for neutrophil extravasation after lung transplantation. (A) Expression levels
of IL-1β were assessed by quantitative real-time PCR in bone marrow–derived B6 WT or MyD88-deficient monocytes after treatment with B6 lung lysates.
Data are expressed as mean ± SEM of 3 biological replicates. **P < 0.01, unpaired t test. (B) Arterial blood oxygenation was assessed and absolute
numbers of recipient (C) monocytes and (D) neutrophils were determined in lung grafts 24 hours after transplantation of B6 CD45.1+ lungs into splenectomized congenic B6 CD45.2+ recipients that received either B6 WT or B6 MyD88-deficient monocytes. (E) Representative contour plots of extravascular vs.
intravascular neutrophils and quantification of the percentages of graft-infiltrated neutrophils in lung grafts as well as (F) number of neutrophils in BALF
24 hours after transplantation of B6 CD45.1+ lungs into splenectomized congenic B6 CD45.2+ recipients that received either B6 WT or B6 MyD88-deficient
monocytes. Data are expressed as median with interquartile range. n = 5 per group. *P < 0.05; **P < 0.01, Mann-Whitey U test (B–F).

hosts 1 hour prior to transplantation of congenic B6 CD45.1 pulmonary grafts. Similarly to our observations with monocytes that lack
IL-1β, oxygenation was significantly improved after injection of
MyD88-deficient when compared with WT monocytes (Figure 6B).
The monocyte and neutrophil numbers that had accumulated in
the pulmonary grafts were comparable between the 2 experimental
groups (Figure 6, C and D); however, a lower percentage of neutrophils extravasated and accumulated in the airways when monocytes
lacked expression of MyD88 (Figure 6, E and F).
IL-1β produced by classical monocytes modulates endothelial tight
junctions through downregulation of ZO-2. Having shown that neutrophils accumulated in lung grafts, but were unable to exit the
vasculature efficiently when graft-infiltrating classical monocytes
lacked expression of IL-1β or when IL-1β signaling in the graft was
disrupted, we next wanted to determine how endothelial permeability was regulated by IL-1β. We observed that exposure of primary
mouse lung microvascular endothelial cells (MLVECs), grown on
Transwell membranes, to IL-1β resulted in a significant increase in
their permeability (Figure 7A). This increase in permeability was
blunted by pretreating the cultures with an IL-1R–blocking antibody
(Figure 7B). To examine downstream mechanisms through which
IL-1β disrupts the pulmonary vascular endothelial barrier, we next
focused on tight junction proteins. Immunofluorescent staining and
Western blotting demonstrated that treatment with IL-1β resulted in
a dose-dependent downregulation of ZO-2, a cytoplasmic protein
that interacts with transmembrane tight junctional proteins (Figure
2840
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7C). Of note, blocking IL-1R signaling attenuated the downregulation of ZO-2 (Figure 7D). We next set out to examine how expression
of IL-1β in graft-infiltrating monocytes regulates these processes
in vivo. Immunofluorescent staining revealed that the expression
of ZO-2 was significantly reduced in CD31+ endothelial cells of B6
lung grafts that were transplanted into splenectomized syngeneic
recipients receiving WT compared with IL-1β–deficient monocytes
(Figure 7E). We also observed significant downregulation of ZO-2 in
human pulmonary grafts following reperfusion (Figure 7F). To elucidate whether downregulation of ZO-2 was sufficient to affect pulmonary endothelial barrier function, an siRNA was used to knock down
ZO-2 expression in MLVECs. The knockdown efficiency of the ZO-2
siRNA was confirmed by Western blotting (Figure 8, A and B) and
immunofluorescent staining of endothelial cell cultures 48 hours
after the transfection (Figure 8C). ZO-2 knockdown resulted in
enhanced endothelial permeability, as measured by the FITC-dextran assay (Figure 8D) and neutrophil transmigration (Figure 8E).

Discussion

Lung IRI remains the predominant cause of early allograft failure
(5, 6, 23, 33, 34). Additionally, it remains the greatest risk factor for
the development of chronic lung allograft rejection. Hence, ameliorating lung IRI has the potential for substantially improving pulmonary transplant outcomes, which still remain dismal compared
with outcomes for transplants with other solid organs. Host neutrophils are now known to play a central role in the development
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Figure 7. IL-1β mediates downregulation of
ZO-2 in vascular endothelial cells and increases
endothelial permeability. Permeability was
assessed in MLVEC cultures treated with (A)
IL-1β at indicated concentrations and (B) after
adding IL-1R–neutralizing (2.5 μg/ml) or control
antibody for 24 hours. For A, a representative
experiment of 3 biological replicates is shown.
Data represent mean ± SD of 3 technical replicates. For B, data are presented as mean ± SD
of 4 biological replicates. One statistical outlier
was excluded in the group receiving IL-1β treatment only. **P < 0.01; ***P < 0.001; ****P <
0.001, 1-way ANOVA with post hoc Holm-Šídák
test (A and B). RFU, relative fluorescence unit.
(C) MLVECs were treated with IL-1β (0, 0.5, and
1 ng/ml) for 24 hours, fixed, and stained with
ZO-2. Nuclei were counterstained with DAPI.
Images are representative of 3 independent
experiments. (D) MLVECs were treated with
IL-1R–neutralizing or control antibody for 30
minutes prior to the addition of IL-1β (1 ng/ml).
Cell lysates were analyzed for ZO-2 by Western
blotting. The same blot was reprobed for GAPDH. Blots are representative of 3 independent
experiments. (E) Frozen tissues of B6 CD45.1+
lung grafts, collected 24 hours after transplantation into splenectomized B6 CD45.2+ hosts that
received B6 WT or B6 IL-1β–deficient monocytes
and (F) human donor grafts at the conclusion of
cold ischemia and 2 hours after reperfusion were
stained with antibodies for ZO-2 (red) and CD31
(green). Nuclei were counterstained with DAPI.
Arrowhead indicates colocalization of CD31 and
ZO-2. Scale bar: 20 μm. Images were taken with
a ×40 objective lens. The relative mean fluorescence intensity (MFI) of ZO-2 staining was
quantified and is represented graphically for E
and F. For E, data are expressed as median with
interquartile range. n = 5 per group. *P < 0.05,
Mann-Whitney U test. For F, n = 8 patients per
group. *P < 0.05, paired t test.

of pulmonary IRI (7–11). Neutrophil trafficking into the injured
tissue involves the recruitment of neutrophils to the lung vasculature, followed by extravasation into the interstitial and alveolar
space (35). In our recent report, we found that donor nonclassical
monocytes provide initial cues for the recruitment of host neutrophils after lung transplantation (21). Here, we demonstrate that
extravasation of neutrophils is mediated by host-derived classical
monocytes mobilized from the spleen to injured lungs following
reperfusion (Figure 9). These classical monocytes produce IL-1β
in MyD88-dependent fashion, which plays a critical and nonredundant role in promoting neutrophil extravasation into the lung
tissue by acting on the IL-1R on the pulmonary vasculature. IL-1β
mediates downregulation of ZO-2 in pulmonary endothelial cells,
which we show is sufficient to disrupt the endothelial barrier.

Many studies have demonstrated that CCR2 plays an important role in mediating the egress of inflammatory monocytes
from the bone marrow (36). To this end, our group has previously demonstrated that CCR2 is critical for the mobilization
of monocytes from the bone marrow into the bloodstream after
pulmonary transplantation and for the accumulation of CD11c+
cells within lung allografts, which enhances alloreactivity (37).
While most studies implicating the bone marrow as the source
of monocytes examined accumulation of monocyte-derived
cells at target sites several days after the inflammatory insult,
recent seminal work using models of myocardial ischemia has
revealed that the spleen represents the dominant reservoir for
monocytes during early stages of inflammation (31). Our findings extend these observations, as we demonstrate by both flow
jci.org   Volume 128   Number 7   July 2018
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Figure 8. Knockdown of ZO-2 increases endothelial permeability. (A and B) Representative Western blot and semiquantitative analysis as well as (C) immunostaining of ZO-2 in MLVECs that were transfected with control siRNA or siRNA targeting ZO-2 for 48 hours. Scale bars: 20 μm. Blots and immunostaining
are representative of 3 independent experiments each. Data are expressed as mean ± SD. n = 6 per group. ****P < 0.0001, 1-way ANOVA with post hoc HolmŠídák test. (D) Endothelial permeability was assessed in MLVECs that were treated with control siRNA or siRNA targeting ZO-2, as described in the legend
for Figure 7A. Data represent mean ± SD of 4 biological replicates. **P < 0.001, unpaired t test. (E) MLVECs were transfected with control siRNA or siRNA targeting ZO-2. Two days later, primary mouse bone marrow–derived neutrophils (1 x 105 cells) were added to the inserts. Twenty-four hours later, transmigrated
neutrophils were enumerated in the lower chamber. Data represent mean ± SD of 3 biological replicates. *P < 0.05, unpaired t test.

cytometry and PET scanning that CCR2+ monocytes are reduced
in the periphery and in the pulmonary graft when we remove
the recipient’s spleen prior to lung IRI. We found that heterotopic spleen grafts were rapidly repopulated by the host classical monocytes, which were then recruited to the injured lung.
We further show that spleen monocytes express higher levels of
IL-1β at baseline and after transplantation. Hence, it is likely that
the spleen serves as a reservoir for bone marrow–derived classical monocytes, where they receive additional maturation signals that enable them to mediate neutrophil extravasation after
their rapid release in response to lung injury. We have previously
demonstrated that CCR2-deficient lung recipients are protected from transplant-mediated IRI and that neutrophils are the
key mediators of IRI after lung transplantation (22, 38). Taken
together, our findings support the notion that splenectomized
lung recipients are protected from IRI through an impairment
of monocyte-mediated neutrophil extravasation into the graft.
Interestingly, we show that — in contrast with our findings in
pulmonary IRI — removal of the spleen does not affect the entry
of neutrophils into the lung when injury is triggered through the
administration of intratracheal LPS or acid aspiration. We speculate that alveolar macrophages play a dominant role in orchestrating the inflammatory response and neutrophil extravasation
when lung injury is triggered through stimuli in the airways. To
this end, intratracheal administration of LPS has been shown to
induce the death of alveolar macrophages, which results in their
release of pro–IL-1α and vascular leakage (39).
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For many years, it had been the prevailing dogma that neutrophils were the first innate cells to enter lung tissue during infections and sterile inflammation. However, the development of
approaches to imaging dynamic leukocyte behavior in live lungs
allowed us to show that monocyte extravasation temporally precedes and is spatially associated with neutrophil extravasation (9).
When we depleted recipient monocytes with intravenous Clo-lip,
graft-infiltrating neutrophils adhered to the vessel wall, but their
extravasation was impaired at the transendothelial migration step.
Disruption of the tight junctions between endothelial cells is a key
event that precedes the paracellular passage of leukocytes. Endothelial tight junction integrity is maintained through the interplay
of protein complexes. Transmembrane tight junctional proteins,
such as claudins, occludins, and junctional adhesion molecules,
are anchored to the actin cytoskeleton through cytosolic scaffold
proteins such as ZO-1 and ZO-2. Here, we show that monocytic production of IL-1β plays a critical and nonredundant role in
increasing endothelial permeability in reperfused lungs. While we
cannot exclude the possibility that IL-1β directly alters the expression of other proteins that maintain the functional integrity of the
endothelial barrier, we show that downregulation of ZO-2 is sufficient to enhance endothelial permeability. It is surprising that
other inflammatory cytokines cannot compensate for IL-1β. For
example, we have shown that graft-infiltrating monocytes express
high levels of TNF-α, a cytokine that has been demonstrated to
increase the permeability of various endothelial and epithelial
cell barriers (40, 41). Differences may exist in how tight junctional
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a murine model of urinary tract infection (45). However,
unlike the critical role that we established for monocytic
production of IL-1β in pulmonary IRI, neutrophilic entry
into bacterially infected urothelium was dependent on the
production of TNF-α by monocytes, which induced the
release of CXCL2 by macrophages, which in turn facilitated the secretion of MMP-9 by neutrophils.
We have recently shown that a population of lung-resident nonclassical monocytes guides neutrophil recruitment to pulmonary grafts after transplantation through
production of the neutrophil chemoattractant CXCL2 (21).
Our present study further demonstrates that graft-resident donor nonclassical monocytes mediate secretion of
monocyte chemoattractants and play an important role in
recruiting recipient spleen-derived classical monocytes to
the graft. Importantly, reconstitution of NR4A1-deficient
donor lungs with WT syngeneic nonclassical monocytes
prior to transplantation restored the recruitment of classical monocytes following reperfusion. Hence, lung-resident
nonclassical monocytes might provide the initial signals
to recruit both classical monocytes and neutrophils from
the periphery, whereas the recruited classical monocytes
mediate the extravasation of the recruited neutrophils. We
also show that classical monocytes that have been recruited to lung grafts express neutrophil chemokines and may
Figure 9. Diagram depicting how spleen-derived classical monocytes mediate
therefore contribute to ongoing neutrophil recruitment and
extravasation of neutrophils in reperfused lungs via MyD88/IL-1β–dependent
propagation of primary graft dysfunction.
pathway. Classical monocytes are released from the spleen after reperfusion of
The demonstration that splenic monocyte-derived
lungs. After recruitment to the lung, they produce IL-1β in MyD88-dependent fashion. IL-1β signaling in endothelial cells results in the downregulation of ZO-2, which
IL-1β orchestrates critical steps of neutrophil entry into the
enhances endothelial permeability and facilitates neutrophil extravasation.
tissue lays the ground for new therapeutic approaches for
lung-transplant recipients and possibly patients suffering
from other forms of acute lung injury. While the removal of
proteins are regulated in various cell types. For example, although
the spleen is not practical in the clinical setting due to its invasive
IFN-γ can disrupt tight junctional proteins in several endothelial
nature and increased risk for infectious complications, our findand epithelial cells (42), it can enhance the function of the lung
ings provide a platform for the development of strategies targetepithelial barrier (43).
ing classical monocytes and inhibiting IL-1β. While no agents that
We speculate that classical monocytes are activated in
selectively deplete classical monocytes in humans are approved
MyD88-dependent fashion once they enter the reperfused lung
at the present time, several immunosuppressants that are in
due to the release of endogenous substances from injured graft
clinical use have been shown to affect monocyte function. For
cells. Our laboratory has previously shown that neutrophilic
example, mTOR inhibitors can blunt the expression of chemokentry into pulmonary graft tissue is impaired when the survival
ines and mycophenolate mofetil can suppress IL-1β production
of alveolar macrophages is reduced (44). This defect could be
in monocytes in vitro (46, 47). Furthermore, as human classical
reversed through administration of CXCL2 into the airways. It
monocytes have been shown to express high levels of CCR2,
is possible that, in addition to downregulating tight junctional
oral CCR2 inhibitors that are in clinical trials for patients with
proteins, graft-infiltrating recipient classical monocytes induce
metastatic pancreatic cancer may be efficacious in ameliorating
the secretion of neutrophil chemokines by tissue-resident donor
primary graft dysfunction after lung transplantation (48). Severcells, such as alveolar macrophages. Collectively, our observaal pharmacological approaches to block the activity of IL-1β are
tions indicate that the production of inflammatory cytokines and
approved for use in the clinic. These include IL-1R antagonists,
chemokines by various cellular sources guides the recruitment
anti–IL-1β neutralizing antibodies, and soluble decoy receptors.
of neutrophils into different compartments of the lung. FurGlobally targeting IL-1β has been shown to be efficacious in amethermore, our work establishes a model whereby an interaction
liorating various inflammatory conditions in humans (49). Also,
between various innate immune cells coordinates the recruitour recently described nanoclusters targeting CCR2 provide a
ment and extravasation of neutrophils, the cells that ultimately
platform to specifically blunt IL-1 production in classical monomediate tissue damage during reperfusion of transplanted lungs.
cytes (22). Previous studies showing monocyte-dependent neuThis is reminiscent of a recent study that demonstrated that
trophil entry in murine arthritis models raise the possibility that
tissue-resident macrophages and inflammatory Ly6Chi monoanalogous mechanisms may regulate sterile inflammation in other organs and tissues (50).
cytes provide cues that guide neutrophils into infected tissue in
jci.org   Volume 128   Number 7   July 2018
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Methods
Mice and reagents
Male B6 (CD45.2+), B6.SJL-PtprcaPepcb/BoyJ (CD45.1+), B6;129S2-
Nr4a1tm1Jmi/J (Nr4a1 KO), B6.129S7-Il1r1tm1Imx/J (IL-1R KO), B6.FVB-Tg(ITGAM-DTR/EGFP)34Lan/J (CD11b-DTR), BALB/c, and B6 Myd88-deficient (MyD88 KO) mice were purchased from The Jackson Laboratory.
B6 LysM–GFP (where LysM indicates lysozyme) mice were originally
obtained from Klaus Ley (La Jolla Institute for Allergy and Immunology,
La Jolla, California, USA), and B6 IL-1β–deficient (IL-1β KO) mice were
obtained from Y. Iwakura (Tokyo University of Science, Chiba, Japan,
USA) and bred in our facility (51). To deplete intravascular monocytes,
mice were injected intravenously with 200 μl Clo-lip with PBS-liposomes
as control 24 hours prior to lung IRI. Clo-lip and PBS-liposomes were
purchased from Liposoma. Cytotoxic anti-CCR2 antibodies (a gift from
Steffen Jung, Weizman Institute of Science, Israel) were used for selective
depletion of CCR2+ classical monocytes as previously described (50 μg
intravenously 24 hours prior to IRI) (21). DT (List Biologic Laboratories
Inc.) was dissolved in 100 μl PBS and administered intraperitoneally to
CD11b-DTR mice 24 hours prior to lung IRI. LPS O111:B4 (Sigma Aldrich)
was dissolved in PBS and instilled intratracheally at a dose of 2 μg/g with
PBS vehicle as control. For acid aspiration injury, 50 μl of hydrochloric
acid (0.1N) was administered into the trachea.
Human samples
Lung graft samples were obtained at the conclusion of cold ischemic
storage in Perfadex solution and approximately 120 minutes following
reperfusion. A portion of the lung tissue was snap-frozen in liquid nitrogen and subsequently stored at –80°C until the time of processing for
gene-expression analysis. A separate portion of lung tissue was fixed
in 4% paraformaldehyde and subsequently processed for immunostaining. Myeloid cell populations were identified from fresh specimens
using multicolor flow cytometry with our previously described protocols
(21, 26, 27). For assessment of neutrophil extravasation, the percentage
and absolute count of neutrophils were assessed in the BALF prior to
lung harvest as well as 15 minutes following reperfusion. Human samples were randomly selected from a cohort of lung-transplant recipients
who had consented to participate in these studies, in which graft tissue
and BALF were collected before implantation and after reperfusion.
Surgical procedures
Murine lung transplantation. Orthotopic left lung transplants were performed after 18 hours of cold ischemic storage as previously described
(9, 44). Graft function was assessed by measuring arterial blood gases
while delivering oxygen at an FiO2 of 100% after clamping the right
pulmonary hilum for 4 minutes, as previously described (24). For
some experiments, recipients were splenectomized or underwent a
sham laparotomy immediately prior to lung transplantation (52). For
adoptive transfer experiments, monocytes were isolated from spleens
or bone marrow of B6 WT, B6 IL-1β–KO, or B6 MyD88-KO mice using
a monocyte isolation kit purchased from Miltenyi Biotec. One hour
prior to lung transplantation, 4 × 105 monocytes were injected via
penile vein into recipients.
Lung hilar clamping. Mice were anesthetized by intraperitoneal
injection of ketamine (100 mg/kg) (Henry Schein Animal Health)
and xylazine (10 mg/kg) (RB). Buprenorphine (0.1 mg/kg) (Lloyd
Laboratories) was given subcutaneously prior to skin incision. Mice
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were orotracheally intubated and connected to a rodent ventilator
(Harvard Apparatus, model 845) with tidal volumes of 10 μl/g and
respiratory rate set at 120 breaths per minute. Left dorsolateral thoracotomy was performed in the fourth intercostal space and a microvascular clamp (Roboz) was applied across the left hilum, occluding
the pulmonary artery, vein, and bronchus. While on single-lung ventilation, the tidal volume was reduced to 6 μl/g and respiratory rate
increased to 150 breaths per minute. The left hilum was occluded
for a 60-minute period, at which point the microvascular clamp was
removed. After recruitment of the left lung, the thoracotomy was
closed and the mouse was removed from the ventilator and allowed
to recover for the 2-hour reperfusion period. For some experiments,
mice were splenectomized or underwent sham laparotomy immediately prior to hilar clamping.
Heterotopic spleen transplantation. The heterotopic spleen transplantation procedure was adapted from a previously published technique
(31). We used congenic CD45.1 donors and CD45.2 recipients to track
donor- and recipient-derived immune cells. In brief, the donor spleen
was harvested with an aortic cuff and the portal vein, ligating all arterial and venous side branches off the splenic artery and vein. The spleen
graft was then implanted in the recipient by anastomosing the donor aortic cuff to the recipient abdominal aorta and the donor portal vein to the
recipient inferior vena cava below the renal veins. The recipient underwent a native splenectomy prior to implantation of the spleen graft.

Flow cytometry and cell sorting
Lung airways were lavaged 5 times with 0.5 ml PBS. BALF was centrifuged, and the cell pellet was processed and prepared for flow
cytometric analysis. After the lavage, lung tissue was digested and
single cell suspensions were prepared as previously described (21, 27,
29). Murine bone marrow was harvested from bilateral femurs and
tibiae and passed through a 40 μm filter to achieve a single cell suspension. Peripheral blood was prepared as previously described (37).
Murine spleen was infiltrated with 2.5 ml of digestion buffer (2 mg/
ml collagenase D, 0.2 mg/ml DNase I, both from Roche, dissolved
in HBSS with Ca2+ and Mn2+), followed by incubation in an orbital
shaker at 37°C for 30 minutes, then pushed through a 40 μm filter
to achieve a single cell suspension. Both bone marrow and spleen
suspensions underwent red blood cell lysis using Pharm Lyse buffer
(BD Biosciences). Live/dead staining was performed in protein-free
solution (HBSS) using fixable viability dye eFluor 506 (eBioscience),
followed by incubation with FcR-blocking reagent (Miltenyi Biotec).
Cells were then stained using CD45 (clone 30-F11; BD Biosciences),
CD45.2 (clone 104; Biolegend), CD45.1 (clone A20; Biolegend), Gr1
(clone RB6-8C5; Biolegend), Ly6C (clone HK1.4; Thermo Fisher Scientific), Ly6G (clone 1A8; Thermo Fisher Scientific), CD11b (clone
M1/70; Thermo Fisher Scientific), CCR2 (clone FAB5538A; R&D
System), CD24 (clone M1/69; Thermo Fisher Scientific), I-A/I-E
(clone M5/114.15.2; BD Biosciences), CD3 (clone 145-2C11; BD Biosciences), CD4 (clone RM4-5; BD Biosciences), CD8α (clone 53.6.7;
Thermo Fisher Scientific), NK1.1 (clone PK136; Thermo Fisher Scientific), CD64 (clone X54-5/7.1; Biolegend), CD115 (clone AFS98;
Thermo Fisher Scientific), SiglecF (clone E50-2440; BD Biosciences), CD19 (clone 1D3; Biolegend), F4/80 (clone BM8; Thermo Fisher Scientific), CD11c (clone HL3; BD Biosciences), CD62L (clone
MEL-14; BD Biosciences), CD117 (clone 2B8; Biolegend), and isotype control antibodies (BD Biosciences; BioLegend; and Thermo
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Fisher Scientific). To distinguish between intravascular and interstitial neutrophils, phycoerythrin-labeled (PE-labeled) anti-Ly6G (1A8;
eBioscience) was injected intravenously 5 minutes prior to sacrifice,
and after digestion, cells were labeled with allophycocyanin-labeled
(APC-labeled) anti-Ly6G (1A8; eBioscience), resulting in labeling
of intravascular neutrophils as PE+APC+ and interstitial neutrophils
as PE−APC+. In separate experiments, intravascular immune cells
were stained with APC-labeled anti-CD45 (30-F11), while the whole
tissue digest was stained with FITC-labeled anti-CD45. For some
experiments examining gene expression, graft-infiltrating spleen
and bone marrow CD90.2–NK1.1–B220 –Ly6G–CD49b –CD11b+CD11cloI-AbloF4/80loLy6Chi monocytes were sorted after staining with
antibodies specific for CD115 (c-fms AFS98; Thermo Fisher Scientific), CD11b, Ly6C, CD45.1, and CD45.2 (Beckman Coulter MoFlo).
Antibodies used for human cell staining were CD45 (clone Hl30,
eBioscience), CD14 (clone M5E2, eBioscience), HLA-DR (clone
L243, eBioscience), CD169 (clone 7-239, BioLegend), CD15 (clone
W6D3, BioLegend), CD11b (clone M1/70, BioLegend), CD16 (clone
3G8, eBioscience), CD163 (clone GHI/61, eBioscience), and CD206
(clone 19.2, eBioscience). Fixed samples were run on a custom LSRFortessa Cell Analyzer (eBioscience). Flow cytometry data were analyzed with FlowJo v10 software.

PET/CT
PET/CT scanning using a CCR2-specific probe was performed as previously described (22, 53). Briefly, 2 hours after transplantation, 0- to
60-minute dynamic PET/CT scanning was performed after the tail
vein injection of 64Cu-radiolabeled DOTA-ECL1i conjugate (64Cu-DOTA-ECL1i, 3.7 MBq in 100 μl saline) using a cross-calibrated MicroPET
Focus 220 (Siemens) or Inveon PET/CT system (Siemens). The tracer
uptake was calculated as the percentage of injected dose per gram of
tissue in the 3D regions of interest from PET images without partial
volume correction using Inveon Research Workplace (Siemens) following this equation: SUV = radioactivity concentration in ROI (Bq/
ml)/(injected dose [Bq]/animal body weight [g]), where SUV = standardized uptake value, Bq = becquerel, and ROI = region of interest.
The quantitative tracer uptake in the ROI was normalized by the
injected radioactivity and animal body weight.
Two-photon microscopy
Lung grafts were imaged by intravital 2-photon microscopy 2 hours
after reperfusion for a time period of 2 hours as previously described
(44, 54). Qdot 655 (30 μl) (Life Technologies) was injected to label vessels. Grafts were exposed and imaged with a custom 2-photon microscope using ImageWarp (A&B Software). Sequential z-sections (2.5
μm each) were acquired, yielding an imaging volume of 220 × 247.5
× 50 μm3. Analyses were performed with Imaris (Bitplane). For each
mouse, up to 5 lung areas at least 80 μm deep were analyzed (44, 54).
Quantitative PCR
Homogenized lung graft tissue, cultured primary MLVECs (Cell Biologics), and sorted monocytes were lysed with TRIzol (Thermo Fisher
Scientific) as previously described (55). Total RNA was isolated using
QIAGEN RNeasy Mini Kit (QIAGEN), and quantitative PCR was performed as previously described (55, 56). Primer sequences for mouse
Tnfa, Cxcl1, Cxcl2, Cxcl5, and Rn18s were previously described (44,
57). Primer sequences for mouse Il1b were 5’-GCAACTGTTCCT-
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GAACTCAACT-3’ and 5’-ATCTTTTGGGGTCCGTCAACT-3’. Primer sequences for human IL1B, TNFA, and RNA18S were as follows:
IL1B: 5′-TTCGACACATGGGATAACGAGG-3′ and 5′-TTTTTGCTGTGAGTCCCGGAG-3′; TNFA: 5′-CCTGCCCCAATCCCTTTATT-3′
and 5′-CCCTAAGCCCCCAATTCTCT-3′; RNA18S: 5′-GGCCCTGTAATTGGAATGAGTC-3′ and 5′-CCAAGATCCAACTACGAGCTT-3′.

Cell transfection
MLVECs were transfected with siRNA targeting ZO-2 (s232643; Thermo
Fisher Scientific) or with control siRNA (AM4611: Thermo Fisher Scientific) and cultured for 48 hours prior to analysis. Concentrations of siRNA
and transfection reagent (Lipofectamine RNAiMAX; Thermo Fisher Scientific) were selected per the manufacturer’s recommendations.
Endothelial permeability assays
MLVEC monolayer solute permeability was assessed using an in
vitro vascular permeability 96-well assay kit (Trevigen). Primary
MLVECs (1 × 105, passages 2–4 were used) were stimulated with various concentrations of IL-1β (R&D Systems; 401-ML) for 24 hours.
Subsequently, monolayer solute permeability was determined by
addition of high–molecular weight FITC-Dextran (Trevigen) to the
Transwell insert. Twenty-four hours later, the fluorescence intensity in the media from the lower chamber was assessed using Bio-Rad
CFX Connect Optical Module. In some experiments, endothelial cell
monolayers were treated with IL-1R neutralization antibody (R&D
Systems; AF771) or control goat IgG (R& D Systems; AB-108-C) for
30 minutes prior to adding IL-1β. Fluorescence intensity was assessed
in triplicate per experimental condition and normalized to untreated
control cells. Primary mouse neutrophils were isolated from the bone
marrow of WT B6 mice based on a negative selection as described
previously (Miltenyi Biotec) (38). MLVECs (1 × 105) were seeded on a
gelatin-coated Transwell membrane with a 3 μm pore size (Corning
Life Science) and cultured for 24 hours. MLVECs were transfected
with an siRNA targeting ZO-2 or with a control siRNA for 2 days as
outlined above. Neutrophils (1 × 105) suspended in 100 μl medium
were added to the Transwell insert after 2 washes with PBS and incubated at 37°C for 24 hours. The number of transmigrated neutrophils
was determined in the lower compartment.
Lung lysate preparation
Homogenized B6 WT lung samples (KINEMATICA Polytron PT
1200) underwent 5 cycles of freeze-thawing in liquid nitrogen and a
37°C water bath. This solution was filtered using a 70 μm strainer, and
diluted supernatants were used to treat monocytes isolated from the
bone marrow of B6 WT or MyD88-KO mice.
Western blotting
Lysates from endothelial cell cultures were prepared using RIPA buffer containing protease inhibitors (P8340; Sigma-Aldrich) and a phosphatase inhibitor (P0044; Sigma-Aldrich) (55). Protein concentrations
were quantitated using a bicinchoninic acid detection assay (Pierce).
The lysates were resolved by SDS-PAGE, transferred to nitrocellulose
membranes, and probed with antibodies against ZO-2 (Novus Biologicals) and GAPDH (Novus Biologicals) (55, 56). The Western blot images were acquired by the ChemiDoc MP image system with Image Lab
Software (version 5.1). The band intensities were quantitated by densitometry using AlphaEase imaging software (version 4.0.1).
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Immunostaining
Frozen lung tissues were prepared and sectioned as previously described
(54). MLVECs were fixed with 4% paraformaldehyde for 15 minutes.
Cells were then permeabilized (0.1% Triton X-100 in PBS for 30 minutes
on ice) and blocked. Tissue sections and cells were stained with antibodies against ZO-2, CD31 (clone P2B1; Abcam), Alexa Fluor 647–conjugated CD14 (clone M5E2; Novus Biologicals), CD15 (clone MY-1; Abcam),
and PE-conjugated CD16 (clone 3G8; BioLegend). ZO-2 was detected
using an Alexa Fluor 555–conjugated secondary antibody, and both
CD31 and CD15 were detected using an Alexa Fluor 488–conjugated
secondary antibody (Thermo Fisher Scientific). Nuclei were stained with
ProLong Gold Antifade Mountant with DAPI (Thermo Fisher Scientific).
Images were acquired with a Zeiss LMS 510 Confocal Laser Scanning
Microscope or Zeiss Observer Fluorescent Microscope using a ×40 water
immersion lens (Zeiss). For both murine and human tissue, intensities
of ZO-2 and DAPI staining were quantitated using Zeiss Efficient Navigation software (ZEN; Zeiss). Relative mean fluorescence intensity of
ZO-2 and DAPI were analyzed. The intensity of ZO-2 was normalized
to that of DAPI. For some experiments, numbers of classical monocytes
(CD14+CD16dim), nonclassical monocytes (CD14+CD16+), and neutrophils (CD15+CD16+) were enumerated at ×40 magnification. For all
experiments, 5 fields per tissue section were randomly chosen, digitally
captured, and analyzed in blinded fashion.
Statistics
Data were analyzed by Prism version 7.0d. For the comparison of 2
groups, data were analyzed with the Mann-Whitney U test or, when indicated, with 2-tailed paired or unpaired t test or the Pearson’s correlation
coefficient test, as described for individual experiments. For multiple
group comparisons, we tested for normality (Shapiro-Wilks test) and
data were analyzed by 1-way ANOVA with post hoc Holm-Šídák test. A
P value of less than 0.05 was considered significant. Statistical outliers
were determined using the GraphPad outlier calculator using α = 0.05.
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